G G Grabenbauer. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useCarboplatin/administration & dosageCarboplatin/therapeutic useCarcinoma, Squamous Cell/blood supplyCarcinoma, Squamous Cell/geneticsCarcinoma, Squamous Cell/pathologyCarcinoma, Squamous Cell/therapyCisplatin/administration & dosageCisplatin/therapeutic useCombined Modality TherapyGenes, bcl-2Genes, p53Head and Neck Neoplasms/blood supplyHead and Neck Neoplasms/geneticsHead and Neck Neoplasms/pathologyHead and Neck Neoplasms/therapyHumansPrognosisProliferating Cell Nuclear AntigenRadiotherapy DosageTime Factors
Substances: See more » Antineoplastic AgentsProliferating Cell Nuclear AntigenCarboplatinCisplatin
Year: 1997 PMID: 9122861 DOI: 10.1007/bf03039278
Source DB: PubMed Journal: Strahlenther Onkol ISSN: 0179-7158 Impact factor: 3.621